Edition:
India

Biosyent Inc (RX.V)

RX.V on TSX Venture Exchange

8.15CAD
23 May 2019
Change (% chg)

-- (--)
Prev Close
$8.15
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
10,393
52-wk High
$10.26
52-wk Low
$6.52

Latest Key Developments (Source: Significant Developments)

Biosyent Reports Q4 EPS AT C$0.11
Wednesday, 20 Mar 2019 

March 20 (Reuters) - Biosyent Inc ::BIOSYENT RELEASES RESULTS FOR FOURTH QUARTER AND FULL YEAR 2018.Q4 EARNINGS PER SHARE C$0.11.Q4 REVENUE ROSE 0.2 PERCENT TO C$5.911 MILLION.Q4 EARNINGS PER SHARE ESTIMATE C$0.10 -- REFINITIV IBES DATA.  Full Article

Biosyent Inc Says Alfred D'souza Has Retired As Chief Financial Officer
Tuesday, 11 Sep 2018 

Sept 10 (Reuters) - Biosyent Inc ::BIOSYENT INC - EFFECTIVE ON SEPTEMBER 10, 2018, ALFRED D'SOUZA HAS RETIRED AS CHIEF FINANCIAL OFFICER OF COMPANY.BIOSYENT INC - D'SOUZA WILL CONTINUE TO ACT IN AN ADVISORY CAPACITY TO COMPANY ON AN ONGOING BASIS.BIOSYENT INC - ROBERT MARCH HAS JOINED BIOSYENT AS VICE PRESIDENT, FINANCE AND CHIEF FINANCIAL OFFICER.  Full Article

BioSyent Q4 Earnings Per Share C$0.10
Wednesday, 21 Mar 2018 

March 21 (Reuters) - BioSyent Inc ::BIOSYENT RELEASES RESULTS FOR FOURTH QUARTER AND FULL YEAR 2017.Q4 EARNINGS PER SHARE C$0.10.Q4 REVENUE ROSE 18 PERCENT TO C$5.901 MILLION.  Full Article

BioSyent reports Q3 earnings per share C$0.09
Wednesday, 15 Nov 2017 

Nov 15 (Reuters) - BioSyent Inc :BioSyent releases results for third quarter and first nine months of 2017.Q3 earnings per share C$0.09.Q3 revenue rose 13 percent to C$5.404 million.  Full Article

BioSyent reports Q2 earnings per share C$0.11
Wednesday, 16 Aug 2017 

Aug 16 (Reuters) - BioSyent Inc :BioSyent releases Q2 AND H1 2017 results.Q2 earnings per share C$0.11.Q2 revenue rose 29 percent to C$5.636 million.  Full Article